Annual Total Debt
$1.30 B
-$9.34 M-0.72%
December 31, 2024
Summary
- As of February 20, 2025, ALNY annual total debt is $1.30 billion, with the most recent change of -$9.34 million (-0.72%) on December 31, 2024.
- During the last 3 years, ALNY annual total debt has risen by +$298.46 million (+29.92%).
- ALNY annual total debt is now -1.83% below its all-time high of $1.32 billion, reached on December 31, 2022.
Performance
ALNY Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$1.30 B
-$5.78 M-0.44%
December 31, 2024
Summary
- As of February 20, 2025, ALNY quarterly total debt is $1.30 billion, with the most recent change of -$5.78 million (-0.44%) on December 31, 2024.
- Over the past year, ALNY quarterly total debt has dropped by -$9.34 million (-0.72%).
- ALNY quarterly total debt is now -2.10% below its all-time high of $1.32 billion, reached on September 30, 2022.
Performance
ALNY Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
ALNY Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.7% | -0.7% |
| 3 y3 years | +29.9% | -0.7% |
| 5 y5 years | +326.6% | -0.7% |
ALNY Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.8% | +29.9% | -2.1% | +30.8% |
| 5 y | 5-year | -1.8% | +326.6% | -2.1% | +326.6% |
| alltime | all time | -1.8% | -100.0% | -2.1% | -100.0% |
Alnylam Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.30 B(-0.7%) | $1.30 B(-0.4%) |
| Sep 2024 | - | $1.30 B(-0.1%) |
| Jun 2024 | - | $1.30 B(+0.2%) |
| Mar 2024 | - | $1.30 B(-0.3%) |
| Dec 2023 | $1.31 B(-1.1%) | $1.31 B(-0.3%) |
| Sep 2023 | - | $1.31 B(-0.4%) |
| Jun 2023 | - | $1.31 B(-0.5%) |
| Mar 2023 | - | $1.32 B(+0.0%) |
| Dec 2022 | $1.32 B(+32.3%) | $1.32 B(-0.3%) |
| Sep 2022 | - | $1.32 B(+33.6%) |
| Jun 2022 | - | $990.98 M(-0.4%) |
| Mar 2022 | - | $995.39 M(-0.2%) |
| Dec 2021 | $997.59 M(+91.4%) | $997.59 M(+31.2%) |
| Sep 2021 | - | $760.44 M(-0.1%) |
| Jun 2021 | - | $761.07 M(+46.8%) |
| Mar 2021 | - | $518.52 M(-0.5%) |
| Dec 2020 | $521.19 M(+71.5%) | $521.19 M(+58.2%) |
| Sep 2020 | - | $329.45 M(+4.6%) |
| Jun 2020 | - | $315.06 M(+3.4%) |
| Mar 2020 | - | $304.82 M(+0.3%) |
| Dec 2019 | $303.82 M(+912.7%) | $303.82 M(-0.3%) |
| Sep 2019 | - | $304.62 M(-9.5%) |
| Jun 2019 | - | $336.56 M(+2.2%) |
| Mar 2019 | - | $329.28 M(+997.6%) |
| Dec 2018 | $30.00 M(0.0%) | $30.00 M(0.0%) |
| Sep 2018 | - | $30.00 M(0.0%) |
| Jun 2018 | - | $30.00 M(0.0%) |
| Mar 2018 | - | $30.00 M(0.0%) |
| Dec 2017 | $30.00 M(-80.0%) | $30.00 M(-80.0%) |
| Sep 2017 | - | $150.00 M(0.0%) |
| Jun 2017 | - | $150.00 M(0.0%) |
| Mar 2017 | - | $150.00 M(0.0%) |
| Dec 2016 | $150.00 M(>+9900.0%) | $150.00 M(0.0%) |
| Sep 2016 | - | $150.00 M(0.0%) |
| Jun 2016 | - | $150.00 M(>+9900.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2008 | - | $3.95 M(-19.6%) |
| Jun 2008 | - | $4.91 M(-16.0%) |
| Mar 2008 | - | $5.84 M(-13.5%) |
| Dec 2007 | $6.76 M(-26.0%) | $6.76 M(-11.7%) |
| Sep 2007 | - | $7.65 M(-10.2%) |
| Jun 2007 | - | $8.52 M(+1.9%) |
| Mar 2007 | - | $8.36 M(-8.5%) |
| Dec 2006 | $9.14 M(+23.5%) | $9.14 M(-3.7%) |
| Sep 2006 | - | $9.48 M(+4.7%) |
| Jun 2006 | - | $9.05 M(+23.6%) |
| Mar 2006 | - | $7.33 M(-0.9%) |
| Dec 2005 | $7.39 M(+2.7%) | $7.39 M(-2.0%) |
| Sep 2005 | - | $7.55 M(-5.2%) |
| Jun 2005 | - | $7.96 M(+2.5%) |
| Mar 2005 | - | $7.77 M(+7.8%) |
| Dec 2004 | $7.20 M(+287.4%) | $7.20 M(+3.3%) |
| Sep 2004 | - | $6.97 M(+22.2%) |
| Jun 2004 | - | $5.71 M(+203.6%) |
| Mar 2004 | - | $1.88 M(+1.1%) |
| Dec 2003 | $1.86 M(>+9900.0%) | $1.86 M(>+9900.0%) |
| Sep 2003 | - | $0.00(0.0%) |
| Jun 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00 |
| Dec 2002 | $0.00 | - |
FAQ
- What is Alnylam Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual total debt year-on-year change?
- What is Alnylam Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly total debt year-on-year change?
What is Alnylam Pharmaceuticals annual total debt?
The current annual total debt of ALNY is $1.30 B
What is the all time high annual total debt for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual total debt is $1.32 B
What is Alnylam Pharmaceuticals annual total debt year-on-year change?
Over the past year, ALNY annual total debt has changed by -$9.34 M (-0.72%)
What is Alnylam Pharmaceuticals quarterly total debt?
The current quarterly total debt of ALNY is $1.30 B
What is the all time high quarterly total debt for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly total debt is $1.32 B
What is Alnylam Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, ALNY quarterly total debt has changed by -$9.34 M (-0.72%)